• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Emerging Biopharma

Clear spirit pouring into a glass
Biotech

Goa Tx launches with vision of creating Narcan for alcohol

GOA26 mimics the body's natural alcohol digestion process, and has already proven effective in rats and pigs.
Darren Incorvaia Sep 17, 2026 3:30pm
Hand passing wad of bills to other hand

Sling reels in $123M to fund oral Tepezza rival through ph. 3

Sep 16, 2026 7:00am
MassBio

Mass. governor acknowledges biotech capital 'harder to come by'

Sep 10, 2026 10:15am
Lilly

Lilly inks $2.88B Merida buyout to expand autoimmune pipeline

Aug 31, 2026 9:18am
Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Pfizer vet debuts Khartis with sights set on thyroid eye disease

Aug 13, 2026 9:00am
cash money

Epicrispr bags $90M to rewrite treatment of rare muscle disease

Aug 11, 2026 10:30am
More News

Caldera hits Nasdaq via Synlogic reverse merger

Jul 29, 2026 8:56am

Lupin seeds US spinout with cash, clinical-stage cancer assets

Jul 21, 2026 8:20am

Biotechs forced to learn new patent tricks to protect pipelines

Jul 12, 2026 12:00pm

Beeline bolsters autoimmune ambitions with $126M

Jun 30, 2026 7:00am
See more stories

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings